Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 4 | 2016 | 361 | 1.160 |
Why?
|
| Cartilage, Articular | 7 | 2021 | 417 | 1.030 |
Why?
|
| Circadian Rhythm | 3 | 2018 | 222 | 0.910 |
Why?
|
| Osteoarthritis | 7 | 2022 | 330 | 0.870 |
Why?
|
| Knee Joint | 5 | 2017 | 745 | 0.580 |
Why?
|
| Arthralgia | 2 | 2018 | 133 | 0.570 |
Why?
|
| Signal Transduction | 4 | 2019 | 437 | 0.550 |
Why?
|
| Animals | 18 | 2022 | 3503 | 0.550 |
Why?
|
| Intervertebral Disc | 5 | 2019 | 117 | 0.540 |
Why?
|
| Mice | 13 | 2022 | 1352 | 0.520 |
Why?
|
| CLOCK Proteins | 2 | 2018 | 13 | 0.520 |
Why?
|
| Protein Kinase C-delta | 1 | 2016 | 10 | 0.500 |
Why?
|
| Axons | 1 | 2016 | 28 | 0.490 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 12 | 0.490 |
Why?
|
| Central Nervous System Depressants | 1 | 2015 | 14 | 0.470 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 72 | 0.450 |
Why?
|
| Joints | 1 | 2015 | 69 | 0.450 |
Why?
|
| Ethanol | 1 | 2015 | 82 | 0.440 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 577 | 0.410 |
Why?
|
| Low Back Pain | 3 | 2019 | 128 | 0.360 |
Why?
|
| Nerve Growth Factor | 2 | 2022 | 43 | 0.310 |
Why?
|
| Lactoferrin | 3 | 2013 | 9 | 0.310 |
Why?
|
| Chondrocytes | 4 | 2021 | 154 | 0.310 |
Why?
|
| Proteoglycans | 5 | 2015 | 131 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2019 | 76 | 0.290 |
Why?
|
| Ganglia, Spinal | 5 | 2022 | 58 | 0.270 |
Why?
|
| Homeostasis | 4 | 2015 | 65 | 0.260 |
Why?
|
| Intervertebral Disc Degeneration | 3 | 2018 | 74 | 0.260 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 266 | 0.240 |
Why?
|
| Interleukin-1 | 3 | 2014 | 49 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 408 | 0.240 |
Why?
|
| Environment | 2 | 2015 | 40 | 0.240 |
Why?
|
| Hyperalgesia | 4 | 2022 | 46 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 37 | 0.220 |
Why?
|
| MicroRNAs | 2 | 2014 | 43 | 0.210 |
Why?
|
| Growth Plate | 2 | 2021 | 15 | 0.210 |
Why?
|
| Cell Differentiation | 2 | 2021 | 132 | 0.200 |
Why?
|
| SOX9 Transcription Factor | 2 | 2021 | 14 | 0.200 |
Why?
|
| Receptor, trkA | 2 | 2022 | 12 | 0.170 |
Why?
|
| Sensory Receptor Cells | 2 | 2022 | 9 | 0.170 |
Why?
|
| Chondrogenesis | 1 | 2021 | 31 | 0.170 |
Why?
|
| Osteoblasts | 1 | 2021 | 57 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 4 | 0.160 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2015 | 20 | 0.150 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2018 | 8 | 0.150 |
Why?
|
| Inflammation | 3 | 2014 | 267 | 0.140 |
Why?
|
| Spinal Puncture | 1 | 2018 | 23 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 31 | 0.140 |
Why?
|
| Analgesics | 1 | 2018 | 79 | 0.140 |
Why?
|
| Disease Progression | 2 | 2017 | 655 | 0.130 |
Why?
|
| Cattle | 5 | 2014 | 122 | 0.130 |
Why?
|
| Triamcinolone | 1 | 2016 | 6 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2013 | 30 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 92 | 0.130 |
Why?
|
| Pain Measurement | 2 | 2019 | 476 | 0.120 |
Why?
|
| Pain | 2 | 2022 | 395 | 0.120 |
Why?
|
| Synovial Membrane | 1 | 2016 | 54 | 0.120 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 30 | 0.120 |
Why?
|
| Body Weight | 1 | 2015 | 132 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 63 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 361 | 0.120 |
Why?
|
| Mutation | 1 | 2016 | 341 | 0.110 |
Why?
|
| Interleukin-11 | 1 | 2013 | 6 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 11 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 50 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2013 | 80 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 317 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 75 | 0.100 |
Why?
|
| Stilbenes | 1 | 2012 | 7 | 0.100 |
Why?
|
| Obesity | 1 | 2015 | 297 | 0.100 |
Why?
|
| Polyphenols | 1 | 2012 | 6 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2013 | 96 | 0.100 |
Why?
|
| Humans | 8 | 2019 | 25967 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2013 | 168 | 0.100 |
Why?
|
| Chondrosarcoma | 1 | 2012 | 42 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 21 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 128 | 0.090 |
Why?
|
| Organ Culture Techniques | 3 | 2016 | 12 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2021 | 25 | 0.080 |
Why?
|
| Osteogenesis | 2 | 2021 | 104 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2014 | 512 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2021 | 297 | 0.070 |
Why?
|
| Collagen Type II | 2 | 2017 | 21 | 0.060 |
Why?
|
| Male | 3 | 2015 | 14277 | 0.060 |
Why?
|
| ADAM Proteins | 2 | 2014 | 41 | 0.050 |
Why?
|
| Rabbits | 2 | 2013 | 179 | 0.050 |
Why?
|
| Tropomyosin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2022 | 30 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 45 | 0.050 |
Why?
|
| Rats | 2 | 2013 | 640 | 0.050 |
Why?
|
| Nucleus Pulposus | 1 | 2018 | 5 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2018 | 26 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2018 | 11 | 0.040 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 6 | 0.040 |
Why?
|
| Neuroglia | 1 | 2018 | 47 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2018 | 52 | 0.040 |
Why?
|
| Integrases | 1 | 2017 | 3 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Endothelium | 1 | 2017 | 13 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2017 | 41 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 25 | 0.030 |
Why?
|
| Antibodies | 1 | 2017 | 45 | 0.030 |
Why?
|
| Bone Development | 1 | 2017 | 30 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 104 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 55 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 214 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2016 | 4 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 28 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 115 | 0.030 |
Why?
|
| Female | 3 | 2018 | 14734 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 87 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2014 | 21 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 51 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 121 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 166 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 633 | 0.030 |
Why?
|
| Vocalization, Animal | 1 | 2013 | 3 | 0.030 |
Why?
|
| Posterior Horn Cells | 1 | 2013 | 3 | 0.030 |
Why?
|
| Horses | 1 | 2013 | 10 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2013 | 24 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 8 | 0.030 |
Why?
|
| Sheep | 1 | 2013 | 18 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 38 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2013 | 47 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 16 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 16 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 368 | 0.030 |
Why?
|
| Dogs | 1 | 2013 | 151 | 0.030 |
Why?
|
| Smad6 Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2013 | 6 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2013 | 6 | 0.030 |
Why?
|
| Alginates | 1 | 2013 | 7 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 66 | 0.030 |
Why?
|
| Cell Survival | 1 | 2013 | 116 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 39 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 80 | 0.030 |
Why?
|
| Aggrecans | 1 | 2013 | 54 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 320 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2013 | 143 | 0.030 |
Why?
|
| Metabolism | 1 | 2012 | 6 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 10 | 0.020 |
Why?
|
| Plants | 1 | 2012 | 7 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 8 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 24 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 28 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 48 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 59 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 19 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 60 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 36 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 67 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 404 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 253 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2012 | 162 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 209 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 200 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 225 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 268 | 0.020 |
Why?
|
| Gait | 1 | 2013 | 408 | 0.020 |
Why?
|
| Adult | 1 | 2013 | 7662 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 8772 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 8732 | 0.010 |
Why?
|